Skip to content

Travis Alvin Thompson, Chief Financial Officer at Bicycle Therapeutics, sold BCYC on Oct 5, 2026

Data as of Oct 16

▼ SELL$28279 shares at $3.57Travis Alvin Thompson Chief Financial OfficerBCYC Bicycle Therapeutics PLC
Watch BCYC
Traded
Oct 5, 2026
Disclosed
Oct 6, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Travis Alvin Thompson, Chief Financial Officer at Bicycle Therapeutics, sold BCYC on Oct 5, 2026TRADEDDISCLOSED
BCYCSimilar stocks (XLV — its sector index fund), rebased to BCYC's price on the disclosure day
BCYC since disclosure
−8.7%
after the sale
Similar stocks (XLV) since disclosure
+5.8%
XLV — its sector index fund

Change in closing price from Oct 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLTravis Alvin Thompson Chief Financial OfficerBCYC Bicycle Therapeutics PLC$3.1Kdisclosed Oct 6 · filed 4 days after the trade

See every trade on BCYC →